169 related articles for article (PubMed ID: 33871818)
1. Evolution of Treatment Paradigms in Newly Diagnosed Multiple Myeloma.
Elnair RA; Holstein SA
Drugs; 2021 May; 81(7):825-840. PubMed ID: 33871818
[TBL] [Abstract][Full Text] [Related]
2. Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review Study.
Gordan LN; Tan CR; Vescio R; Ye JC; Schinke C; Medhekar R; Fu AZ; Lafeuille MH; Thompson-Leduc P; Khare V; Reitan J; Milkovich G; Kaila S; Davies F; Usmani SZ
Clin Lymphoma Myeloma Leuk; 2024 Jan; 24(1):55-63. PubMed ID: 37838502
[TBL] [Abstract][Full Text] [Related]
3. [Updated treatment strategy for transplant-eligible multiple myeloma: current status and future perspectives].
Tsukada N
Rinsho Ketsueki; 2023; 64(9):1066-1073. PubMed ID: 37899184
[TBL] [Abstract][Full Text] [Related]
4. Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review.
McCaughan GJ; Gandolfi S; Moore JJ; Richardson PG
Br J Haematol; 2022 Oct; 199(2):190-204. PubMed ID: 35796524
[TBL] [Abstract][Full Text] [Related]
5. Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma.
Richardson PG; Durie BG; Rosiñol L; Mateos MV; Dispenzieri A; Moreau P; Kumar S; Raje N; Munshi N; Laubach JP; O'Gorman P; O'Donnell E; Voorhees P; Facon T; Bladé J; Lonial S; Perrot A; Anderson KC
Haematologica; 2023 Nov; 108(11):2894-2912. PubMed ID: 37608773
[TBL] [Abstract][Full Text] [Related]
6. Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple Myeloma.
Lonial S; Bowser AD; Chari A; Costello C; Krishnan A; Usmani SZ
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):815-824. PubMed ID: 37516547
[TBL] [Abstract][Full Text] [Related]
7. From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.
Gay F; Engelhardt M; Terpos E; Wäsch R; Giaccone L; Auner HW; Caers J; Gramatzki M; van de Donk N; Oliva S; Zamagni E; Garderet L; Straka C; Hajek R; Ludwig H; Einsele H; Dimopoulos M; Boccadoro M; Kröger N; Cavo M; Goldschmidt H; Bruno B; Sonneveld P
Haematologica; 2018 Feb; 103(2):197-211. PubMed ID: 29217780
[TBL] [Abstract][Full Text] [Related]
8. Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma.
Dimopoulos MA; Jakubowiak AJ; McCarthy PL; Orlowski RZ; Attal M; Bladé J; Goldschmidt H; Weisel KC; Ramasamy K; Zweegman S; Spencer A; Huang JSY; Lu J; Sunami K; Iida S; Chng WJ; Holstein SA; Rocci A; Skacel T; Labotka R; Palumbo A; Anderson KC
Blood Cancer J; 2020 Feb; 10(2):17. PubMed ID: 32054831
[TBL] [Abstract][Full Text] [Related]
9. First-line treatment of multiple myeloma in both transplant and non-transplant candidates.
Oriol A; Abril L; Ibarra G
Expert Rev Anticancer Ther; 2023 Jul; 23(7):685-698. PubMed ID: 37194283
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic progress in relapsed/refractory multiple myeloma.
Chen Q; Zhang M; Zheng S; Tong Y; Tan Y
Ann Hematol; 2024 Jun; 103(6):1833-1841. PubMed ID: 38609727
[TBL] [Abstract][Full Text] [Related]
11. Progress and Paradigms in Multiple Myeloma.
Anderson KC
Clin Cancer Res; 2016 Nov; 22(22):5419-5427. PubMed ID: 28151709
[TBL] [Abstract][Full Text] [Related]
12. Novel therapies for multiple myeloma.
Wallington-Beddoe CT; Pitson SM
Aging (Albany NY); 2017 Aug; 9(8):1857-1858. PubMed ID: 28854147
[No Abstract] [Full Text] [Related]
13. Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.
Maura F; Boyle EM; Coffey D; Maclachlan K; Gagler D; Diamond B; Ghamlouch H; Blaney P; Ziccheddu B; Cirrincione A; Chojnacka M; Wang Y; Siegel A; Hoffman JE; Kazandjian D; Hassoun H; Guzman E; Mailankody S; Shah UA; Tan C; Hultcrantz M; Scordo M; Shah GL; Landau H; Chung DJ; Giralt S; Zhang Y; Arbini A; Gao Q; Roshal M; Dogan A; Lesokhin AM; Davies FE; Usmani SZ; Korde N; Morgan GJ; Landgren O
Nat Cancer; 2023 Dec; 4(12):1660-1674. PubMed ID: 37945755
[TBL] [Abstract][Full Text] [Related]
14. Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies.
Rees MJ; D'Agostino M; Leypoldt LB; Kumar S; Weisel KC; Gay F
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e433520. PubMed ID: 38772002
[TBL] [Abstract][Full Text] [Related]
15. Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti-CD38 monoclonal antibody.
Seth A; Murray D; Buadi FK; Gertz MA; Yadav U; Kumar SK; Gonsalves WI
Eur J Haematol; 2023 Aug; 111(2):318-321. PubMed ID: 37209032
[TBL] [Abstract][Full Text] [Related]
16. Current approaches to the initial treatment of symptomatic multiple myeloma.
Jasielec JK; Jakubowiak AJ
Int J Hematol Oncol; 2013 Feb; 2(1):. PubMed ID: 24286003
[TBL] [Abstract][Full Text] [Related]
17. The pharmacologic management of multiple myeloma in older adults.
Dempsey JL; Johns A; Rosko AE; Lazarus HM
Expert Opin Pharmacother; 2019 May; 20(7):887-902. PubMed ID: 30785310
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with multiple myeloma progressing on frontline-therapy with lenalidomide.
Moreau P; Zamagni E; Mateos MV
Blood Cancer J; 2019 Mar; 9(4):38. PubMed ID: 30894516
[TBL] [Abstract][Full Text] [Related]
19. The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma.
Bonello F; Grasso M; D'Agostino M; Celeghini I; Castellino A; Boccadoro M; Bringhen S
Pharmaceuticals (Basel); 2020 Dec; 14(1):. PubMed ID: 33383757
[TBL] [Abstract][Full Text] [Related]
20. Considerations for next therapy after anti-CD38 monoclonal antibodies used as first line.
Hartley-Brown M; Zinkeng A
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):443-449. PubMed ID: 38066885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
